Physician profile
Benjamin A Uhl
NPI 1437311792
$3,191.58
in general payments reported to CMS, 2019-2025
19 companies · $894 in 2025
The $894 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $414 · 2020: $145 · 2021: $393 · 2022: $448 · 2023: $430 · 2024: $469 · 2025: $894.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,777 · Entertainment: $15.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,776.72 |
| Entertainment | $15.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $862.40 | 2019-2025 | Precision7, Total30, Dailies Total1 |
| Bausch & Lomb Americas INC. | $380.53 | 2022-2025 | Xiidra, Miebo, Btod |
| Coopervision INC. | $300.67 | 2019-2025 | Misight Contact Lens, Clariti Contact Lens |
| Biotissue Holdings INC. | $287.09 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $237.20 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $170.07 | 2020-2023 | Cequa |
| Glaukos Corporation | $164.70 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $151.50 | 2019-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $117.22 | 2019-2021 | |
| Allergan, INC. | $103.75 | 2021-2022 | |
| Amgen INC. | $92.31 | 2025 | Tepezza |
| Horizon Therapeutics Plc | $87.90 | 2023 | Tepezza |
| Sight Sciences, INC. | $68.78 | 2019 | |
| Novartis Pharmaceuticals Corporation | $60.97 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $34.15 | 2025 | Acthar |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $23.15 | 2022 | |
| Dompe US, INC. | $20.30 | 2025 | Oxervate |
| Optos, INC. | $15.38 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Shire North American Group INC | $13.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Uhl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.